HHS aims to use value-based care payment models to lower drug prices

September 9, 2021Garrett SchmittNo CommentsCMMI, drug prices, HHS, Pharmaceuticals

The Department of Health and Human Services wants to test models that would pay drugs based on their clinical value as part of a new plan to tackle high prices. The plan released Thursday lays out several administrative tools the agency plans to take to address high prices. It also calls on Congress to adopt several reforms…

Recent Posts

  • RECORDED WEBINAR: Imagine Having Complete ADT Feeds with Actionable Data
  • Targeting 4 More Years and Scaling Value-Based Care Models in 2026
  • How states are responding to expiring ACA subsidies
  • CMS launches updated ACO model: 5 things to know
  • Maternity Care Bundled Payments In The Netherlands: Changes In Health Outcomes, Spending, And Care Delivery After 5 Years
 
  • Main Lobby
  • Exhibit Hall
  • Events
  • Exhibit With Us
  • Board Room
  • Library
  • Contact Us